Both in Pharmaceuticals
Revelation Biosciences vs Jupiter Neurosciences
Over the past year REVB returned −85.6% and JUNS returned −98.2%; their daily moves had a correlation of -0.03.
REVB −85.6% JUNS −98.2%Growth of $1, one year, split-adjusted
| Metric | REVB | JUNS |
|---|---|---|
| Price | $0.8170 | $2.44 |
| Market cap | $3.3M | $3.2M |
| Today | +0.37% | −5.43% |
| 1 month | −18.3% | −31.1% |
| 6 months | −31.9% | −91.4% |
| Year to date | −74.5% | −96.8% |
| 1 year | −85.7% | −98.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 86.9% |
| Net margin | — | −9380.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 49.7× |
| Net cash | $11.5M | -$6.6K |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 1,269.4% |
| Short % of float | 0.0% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).